Tazeen Ahmad
Stock Analyst at Bank of America Securities
(4.70)
# 737
Out of 4,509 analysts
980
Total ratings
62.3%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Reiterated: Sell | $307 → $312 | $363.39 | -14.14% | 5 | Jul 13, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $162 | $129.83 | +24.78% | 10 | Jul 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Buy | $860 → $856 | $664.52 | +28.81% | 12 | Jul 13, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $598 → $600 | $485.39 | +23.61% | 25 | Jul 13, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,088 | $877.62 | +23.97% | 63 | Jul 13, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $460 | $298.76 | +53.97% | 47 | Jul 10, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $45 | $30.57 | +47.20% | 1 | Jul 6, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $768.00 | - | 7 | Jul 2, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $110 → $125 | $119.35 | +4.73% | 16 | Jun 30, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterated: Buy | $30 | $26.22 | +14.42% | 46 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $288 | $270.45 | +6.49% | 70 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $10.20 | +164.71% | 20 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $10 | $6.34 | +57.73% | 6 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $11.11 | +143.02% | 1 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $124 | $116.71 | +6.25% | 53 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $149 | $108.40 | +37.45% | 42 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $149.33 | +33.93% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $131 | $133.65 | -1.98% | 6 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $3 | $3.50 | -14.29% | 23 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.91 | - | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $91.49 | +36.63% | 53 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.68 | - | 20 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $2.2 | $3.10 | -29.03% | 12 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $29.73 | - | 13 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $2.34 | +28.21% | 21 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $33 | $26.48 | +24.62% | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $4 | $7.60 | -47.37% | 2 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $84.85 | - | 49 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $31 → $33 | $35.07 | -5.90% | 18 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $9.24 | -13.42% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $56.71 | +2.27% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.80 | +37.93% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.45 | - | 35 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $33.82 | - | 46 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $177.11 | - | 46 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $8.27 | +69.29% | 22 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 | $18.95 | +0.26% | 69 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $1.68 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $82 → $79 | $12.31 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $1 | $1.29 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.67 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $4.81 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $324.99 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $23.19 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $9 | $16.93 | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $8 | $1.18 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $68.27 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $28 | $17.54 | n/a | 1 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $1.61 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $16.49 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 → $48 | $25.48 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $6.11 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $8.83 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $2.10 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $5.61 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $91.88 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $22.24 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $51.24 | n/a | 1 | Sep 19, 2014 |
Amgen
Jul 13, 2026
Reiterated: Sell
Price Target: $307 → $312
Current: $363.39
Upside: -14.14%
Gilead Sciences
Jul 13, 2026
Reiterated: Buy
Price Target: $162
Current: $129.83
Upside: +24.78%
Regeneron Pharmaceuticals
Jul 13, 2026
Reiterated: Buy
Price Target: $860 → $856
Current: $664.52
Upside: +28.81%
Vertex Pharmaceuticals
Jul 13, 2026
Reiterated: Buy
Price Target: $598 → $600
Current: $485.39
Upside: +23.61%
argenx SE
Jul 13, 2026
Maintained: Buy
Price Target: $1,088
Current: $877.62
Upside: +23.97%
Alnylam Pharmaceuticals
Jul 10, 2026
Maintained: Buy
Price Target: $460
Current: $298.76
Upside: +53.97%
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $30.57
Upside: +47.20%
argenx SE
Jul 2, 2026
Maintained: Buy
Price Target: n/a
Current: $768.00
Upside: -
Kymera Therapeutics
Jun 30, 2026
Reiterated: Buy
Price Target: $110 → $125
Current: $119.35
Upside: +4.73%
ACADIA Pharmaceuticals
Jun 29, 2026
Reiterated: Buy
Price Target: $30
Current: $26.22
Upside: +14.42%
Jun 29, 2026
Maintained: Buy
Price Target: $288
Current: $270.45
Upside: +6.49%
Jun 22, 2026
Reiterated: Buy
Price Target: $27
Current: $10.20
Upside: +164.71%
Jun 22, 2026
Reiterated: Buy
Price Target: $9 → $10
Current: $6.34
Upside: +57.73%
Jun 18, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $11.11
Upside: +143.02%
Jun 15, 2026
Maintained: Buy
Price Target: $124
Current: $116.71
Upside: +6.25%
Jun 15, 2026
Maintained: Buy
Price Target: $149
Current: $108.40
Upside: +37.45%
Jun 15, 2026
Maintained: Buy
Price Target: $200
Current: $149.33
Upside: +33.93%
Jun 11, 2026
Maintained: Buy
Price Target: $131
Current: $133.65
Upside: -1.98%
Jun 2, 2026
Maintained: Sell
Price Target: $8 → $3
Current: $3.50
Upside: -14.29%
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $28.91
Upside: -
Jun 1, 2026
Maintained: Buy
Price Target: $125
Current: $91.49
Upside: +36.63%
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $25.68
Upside: -
May 21, 2026
Reiterated: Hold
Price Target: $2 → $2.2
Current: $3.10
Upside: -29.03%
May 21, 2026
Reiterated: Sell
Price Target: n/a
Current: $29.73
Upside: -
May 21, 2026
Reiterated: Sell
Price Target: $3
Current: $2.34
Upside: +28.21%
May 21, 2026
Reiterated: Buy
Price Target: $35 → $33
Current: $26.48
Upside: +24.62%
May 15, 2026
Downgraded: Sell
Price Target: $18 → $4
Current: $7.60
Upside: -47.37%
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $84.85
Upside: -
May 14, 2026
Maintained: Hold
Price Target: $31 → $33
Current: $35.07
Upside: -5.90%
May 8, 2026
Reiterated: Sell
Price Target: $8
Current: $9.24
Upside: -13.42%
May 8, 2026
Reiterated: Buy
Price Target: $58
Current: $56.71
Upside: +2.27%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $5.80
Upside: +37.93%
Apr 16, 2026
Maintained: Buy
Price Target: n/a
Current: $10.45
Upside: -
Apr 16, 2026
Maintained: Buy
Price Target: n/a
Current: $33.82
Upside: -
Apr 15, 2026
Maintained: Buy
Price Target: n/a
Current: $177.11
Upside: -
Mar 18, 2026
Reiterated: Hold
Price Target: $14
Current: $8.27
Upside: +69.29%
Feb 25, 2026
Reiterated: Sell
Price Target: $19
Current: $18.95
Upside: +0.26%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $1.68
Upside: n/a
Sep 19, 2024
Maintained: Buy
Price Target: $82 → $79
Current: $12.31
Upside: n/a
Oct 17, 2023
Maintained: Sell
Price Target: $2 → $1
Current: $1.29
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $2.67
Upside: n/a
Mar 27, 2023
Maintained: Sell
Price Target: $6
Current: $4.81
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $324.99
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $23.19
Upside: n/a
Apr 19, 2022
Maintained: Sell
Price Target: $10 → $9
Current: $16.93
Upside: n/a
Jul 21, 2021
Maintained: Buy
Price Target: $16 → $8
Current: $1.18
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $68.27
Upside: n/a
Jun 3, 2019
Initiated Coverage: Hold
Price Target: $28
Current: $17.54
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $1.61
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $16.49
Upside: n/a
Oct 10, 2018
Maintained: Hold
Price Target: $46 → $48
Current: $25.48
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $6.11
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $8.83
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $2.10
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $5.61
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $91.88
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $22.24
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $51.24
Upside: n/a